As I have said many times, viscosity is a factor for a successful treatment. This consideration comes from Okyano's clinical experience.
CYTX;s celution system would work here in the US - some preclinical works and then some more clinical development may lead to a very successful phase 3 for FDA approval. CYTX needs cash to go in the last few miles.
Osteoarthritis would be a big indication to go after.